MP:0001360 | abnormal social investigation | "altered behavior of animals to approach and examine other animals" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0001363 | increased anxiety-related response | "when compared to controls, subjects exhibit more responses thought to be indicative of anxiety in behavioral tests" [cwg:Carroll-Ann W. Goldsmith, Mouse Genome Informatics curator, J:49752, J:53060] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0002797 | thigmotaxis | "preference of a mouse for the side walls of a cage or box; usually an indicator of increased anxiety response" [J:56814] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0003063 | increased coping response | "enhanced ability to respond productively to a stressful situation" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0003661 | abnormal locus ceruleus | "anomaly in a dense cluster of neurons within the dorsorostral pons; it is the major location of neurons that release norepinephrine throughout the brain, and is responsible for physiological responses to stress and panic" [J:96328, Principles of Neural Science , 3rd edition:ISBN 0-8385-8034-3] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0004000 | impaired passive avoidance behavior | "decrease in or absence of the latency of an animal to enter an hostile environment where it receives a unpleasant or punishing stimuli applied previously" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0005584 | abnormal enzyme/coenzyme activity | "altered ability of any of these proteins, or their cofactors, to act as catalysts to induce chemical changes in other substances" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0010070 | decreased serotonin concentration | "reduction in the amount per unit of biochemical messenger and regulator, found in the CNS, gastrointestinal tract, and produced by platelets that mediates neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity" [ISBN:0-683-40008-8 "Stedman s Medical Dictionary, 27th edition"] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|
MP:0012574 | decreased noradrenaline level | "reduced amount of the hormone secreted by the adrenal medulla and acts as a neurotransmitter in the sympathetic peripheral nervous system and in some tracts of the CNS; noradrenaline is the demethylated biosynthetic precursor of epinephrine" [http://orcid.org/0000-0001-5208-3432, ISBN:0198506732] |
Show
Allelic Composition: Fbxo11tm2a(EUCOMM)Wtsi/Fbxo11tm2a(EUCOMM)Wtsi Genetic Background: involves: C57BL/6N
|